Ventricular tachycardia ablation associated abnormalities on FDG PET/CT in patients with suspected cardiac sarcoidosis
Authors:
- Brigitte KazziBKBrigitte Kazzi
- Stephen J HankinsonSHStephen J Hankinson
- Sylvain L CarreSCSylvain L Carre
- Jon HainerJHJon Hainer
- Akshay S DesaiADAkshay S Desai
- Garrick C StewartGSGarrick C Stewart
- Neal K LakdawalaNLNeal K Lakdawala
- Michael M GivertzMGMichael M Givertz
- Ron BlanksteinRBRon Blankstein
- Marcelo F Di CarliMCMarcelo F Di Carli
- Bruce A KoplanBKBruce A Koplan
- Usha B TedrowUTUsha B Tedrow
Open Access
- 14 March 2026
- journal article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 28 (4)
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (T32HL094301-15)
- Brigham and Women's Hospital
This publication has 7 references indexed in Scilit:
- Diagnoses and outcomes of patients referred for FDG PET/CT for suspected cardiac sarcoidosisInternational Journal of Cardiology, 2025
- Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart AssociationCirculation, 2024
- Diagnostic Accuracy of Advanced Imaging in Cardiac SarcoidosisCirculation: Cardiovascular Imaging, 2019
- HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac SarcoidosisHeart Rhythm, 2014
- Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac SarcoidosisJACC, 2014
- 18F-FDG PET after radiofrequency ablation: Is timing everything?2006
- 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.2006